Vineet Laboratories balance sheet

As of Mar 2026

Total assets: ₹125cr+32.0% on Mar 2025
Shareholders' equity: ₹45.6cr+211.3% on Mar 2025
Total debt: ₹45.3cr+13.2% on Mar 2025
Cash and investments: ₹16.7cr+5,343.5% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	24.2	25.5	26.9	26.6
	0.0	0.2	—	0.0
	0.2	0.0	0.2	0.1
	0.8	0.0	0.0	0.0
	0.7	0.8	1.6	1.3
	1.7	0.8	1.8	1.4
	0.0	0.7	—	0.3
	26.0	27.1	28.7	28.4
	64.1	50.0	49.4	46.2
	11.4	13.2	31.6	35.2
	16.7	0.3	0.2	0.6
	0.4	0.4	0.2	0.3
	0.0	0.0	0.1	0.0
	0.0	3.5	6.7	0.0
	28.5	17.4	38.8	36.1
	6.3	0.0	—	5.1
	98.8	67.4	88.2	87.5
	125	94.5	117	116
Equity
	19.2	9.2	9.2	9.2
	26.4	5.4	25.5	24.5
	45.6	14.6	34.7	33.7
	45.6	14.6	34.7	33.7
Liabilities
	10.2	3.8	3.9	4.8
	10.2	3.8	3.9	4.8
	0.4	0.8	0.8	0.8
	1.3	0.9	1.5	2.1
	11.9	5.5	6.2	7.7
	35.1	36.3	40.4	26.2
	25.3	33.6	32.3	34.9
	0.4	0.1	0.4	0.3
	60.9	69.9	73.1	61.4
	0.1	0.4	0.5	0.3
	0.0	0.0	0.1	0.4
	6.3	4.0	2.3	12.3
	67.3	74.4	76.0	74.5
	79.2	79.9	82.1	82.2
	125	94.5	117	116
Trade payables — MSME split
	9.7	6.2	—	—
	15.6	27.4	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

VINEETLAB₹36.06

Vineet Laboratories Limited

· Pharma & Health

₹ CrorePeersBIOFILCHEM MANGALAM LASA KREBSBIO ALPA BALPHARMA ORTINGLOBE NATCAPSUQMcap ₹69.3 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	26.6	26.9	25.5	24.2	24.2
+ Investments (Equity Method)	0.0	—	0.2	0.0	0.0
+ Non-current Investments	0.1	0.2	0.0	0.2	0.2
+ Long-term Loans	0.0	0.0	0.0	0.8	0.8
+ Other Non-current Financial Assets	1.3	1.6	0.8	0.7	0.7
Non-current Financial Assets	1.4	1.8	0.8	1.7	1.7
+ Other Non-current Assets	0.3	—	0.7	0.0	0.0
Total Non-current Assets	28.4	28.7	27.1	26.0	26.0
Current Assets
+ Inventories	46.2	49.4	50.0	64.1	64.1
+ Trade Receivables	35.2	31.6	13.2	11.4	11.4
+ Cash & Cash Equivalents	0.6	0.2	0.3	16.7	16.7
+ Other Bank Balances	0.3	0.2	0.4	0.4	0.4
+ Short-term Loans	0.0	0.1	0.0	0.0	0.0
+ Other Current Financial Assets	0.0	6.7	3.5	0.0	0.0
Current Financial Assets	36.1	38.8	17.4	28.5	28.5
+ Other Current Assets	5.1	—	0.0	6.3	6.3
Total Current Assets	87.5	88.2	67.4	98.8	98.8
Total Assets	115.8	116.9	94.5	124.8	124.8
Equity
+ Equity Share Capital	9.2	9.2	9.2	19.2	19.2
+ Other Equity / Reserves	24.5	25.5	5.4	26.4	26.4
Equity — Owners of Parent	33.7	34.7	14.6	45.6	45.6
Total Equity	33.7	34.7	14.6	45.6	45.6
Liabilities
+ Borrowings — Non-current	4.8	3.9	3.8	10.2	10.2
Non-current Financial Liabilities	4.8	3.9	3.8	10.2	10.2
+ Provisions — Non-current	0.8	0.8	0.8	0.4	0.4
+ Deferred Tax Liabilities	2.1	1.5	0.9	1.3	1.3
Non-current Liabilities	7.7	6.2	5.5	11.9	11.9
+ Borrowings — Current	26.2	40.4	36.3	35.1	35.1
+ Trade Payables	34.9	32.3	33.6	25.3	25.3
+ Other Current Financial Liab	0.3	0.4	0.1	0.4	0.4
Current Financial Liabilities	61.4	73.1	69.9	60.9	60.9
+ Provisions — Current	0.3	0.5	0.4	0.1	0.1
+ Current Tax Liabilities	0.4	0.1	0.0	0.0	0.0
+ Other Current Liabilities	12.3	2.3	4.0	6.3	6.3
Current Liabilities	74.5	76.0	74.4	67.3	67.3
Total Liabilities	82.2	82.1	79.9	79.2	79.2
Total Equity & Liabilities	115.8	116.9	94.5	124.8	124.8
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	6.2	9.7	9.7
+ Dues to Other Creditors — Current	—	—	27.4	15.6	15.6
Regulatory Disclosures — filed alongside, not part of the B/S
+ Funds Utilised	—	—	—	—	2.8
+ Original Allocation	—	—	—	—	2.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.